Sartorius Stedim Biotech S.A. Non-GAAP EPS of Euro4.40, revenue of Euro2.97B; initates FY26 outlook
Source: SeekingAlpha
2026-02-03 01:29:02 ET
More on Sartorius Stedim Biotech S.A.
- Seeking Alpha’s Quant Rating on Sartorius Stedim Biotech S.A.
- Historical earnings data for Sartorius Stedim Biotech S.A.
- Dividend scorecard for Sartorius Stedim Biotech S.A.
- Financial information for Sartorius Stedim Biotech S.A.
Read the full article on Seeking Alpha
For further details see:
Sartorius Stedim Biotech S.A. Non-GAAP EPS of €4.40, revenue of €2.97B; initates FY26 outlook
Sartorius Stedim Biotech S.A. - ADR
NASDAQ: SRTOY
SRTOY Trading
3.57% G/L:
$19.1599 Last:
2,221 Volume:
$18.8801 Open:
